These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 6241750)

  • 1. Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy.
    Fritschi J; Christe M; Lämmle B; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Dec; 52(3):236-9. PubMed ID: 6241750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseases.
    Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaliman J
    Artery; 1980; 8(1):73-9. PubMed ID: 6158934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contact phase of blood coagulation in diabetes mellitus and in patients with vasculopathy.
    Christe M; Gattlen P; Fritschi J; Lämmle B; Berger W; Marbet GA; Duckert F
    Thromb Haemost; 1984 Dec; 52(3):221-3. PubMed ID: 6085193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemostasis in diabetics.
    Misz M; Beck P; Udvardy M; Rák K
    Acta Med Hung; 1984; 41(2-3):93-102. PubMed ID: 6235479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of the level of plasma beta-thromboglobulin in diabetes].
    Stoltz JF; Voisin P; Drouin P; Pointel JP; Benisti G
    Biomedicine; 1980; 33(6):194-6. PubMed ID: 6163487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
    Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
    Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of various parameters of platelet function in subjects with type II diabetes mellitus. Methodologic study of the changes in PF4 and beta-TG].
    Ferri GM; Afeltra A; Caccavo D; Amoroso A
    Recenti Prog Med; 1986 Jan; 77(1):31-2. PubMed ID: 2422709
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased platelet activity in diabetic macroangiopathy.
    Diamantopoulos EJ; Raptis SA; Moulopoulos SD
    Horm Metab Res Suppl; 1992; 26():95-102. PubMed ID: 1490701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
    Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
    Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered platelet function in diabetes mellitus.
    Colwell JA; Halushka PV; Sarji K; Levine J; Sagel J; Nair RM
    Diabetes; 1976; 25(2 SUPPL):826-31. PubMed ID: 823064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet factor 4 (PF4) and heparin released platelet factor 4 (HR-PF4) in diabetes mellitus. Effect of the duration of the disease.
    Cella G; Scattolo N; Vio C; Stevanato F; Lavagnini T; Padovan D; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):646-54. PubMed ID: 2435630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of the radioimmunological determination of beta-thromboglobulin and platelet factor 4].
    Schernthaner G; Silberbauer K; Mühlhauser I; Willvonseder R
    Acta Med Austriaca Suppl; 1979; 6():375-9. PubMed ID: 95543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelets and diabetic vascular disease.
    Paton RC; Passa P
    Diabete Metab; 1983 Dec; 9(4):306-12. PubMed ID: 6230270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet aggregation and plasma levels of beta-thromboglobulin in diabetes mellitus.
    Yamada K; Mori K; Goto Y
    Tohoku J Exp Med; 1981 Dec; 135(4):423-9. PubMed ID: 6175049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma and urine beta-thromboglobulin determination in the detection of thrombocyte hyperactivation in diabetic nephropathies].
    Tóth L; Szénási P; Varsányi-Nagy M; Szilvási I; Lehoczky E; Németh C; Kammerer L; Romics L
    Orv Hetil; 1991 May; 132(21):1135-8, 1141. PubMed ID: 1828563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of thrombotic risk in type 2 diabetes: determination of platelet factor 4 and beta thromboglobulin].
    Diop S; Ka-Cisse M; Toure-Fall AO; Diagne Fall-Sarr F; Diop SN; Thiam D; Diakhate L
    Dakar Med; 2002; 47(2):247-51. PubMed ID: 15776686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pressure excursions on human platelets. In vitro studies on betathromboglobulin (beta-TG) and platelet factor 4 (PF4) release and on platelet sensitivity to ADP-aggregation.
    Torsellini A; Becucci A; Citi S; Cozzolino F; Guidi G; Lombardi V; Vercelli D; Veloci M
    Haematologica; 1982; 67(6):860-6. PubMed ID: 6186580
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet function in diabetic retinopathy: levels of beta-thromboglobulin and platelet factor 4.
    Fenández-Vigo J; Cordido M; Fernández Sabugal J; Cordido F
    Metab Pediatr Syst Ophthalmol (1985); 1992; 15(1-3):5-8. PubMed ID: 1484500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of platelets in complicated and uncomplicated diabetes mellitus.
    Malhotra KC; Arya RK; Chugh SN; Singla BB
    Angiology; 1982 Jun; 33(6):410-7. PubMed ID: 7091771
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma beta-thromboglobulin to platelet factor 4 ratios as indices of vascular complications in essential hypertension.
    Gomi T; Ikeda T; Yuhara M; Sakurai J; Nakayama D; Ikegami F
    J Hypertens; 1988 May; 6(5):389-92. PubMed ID: 2968397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.